Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Oncology Research and Treatment

Vol. 40, No. 10, 2017

Issue release date: October 2017

Add all to MyReading List
 
569

Editorial Board / Contents / Imprint

Oncol Res Treat 2017;40:569-572 (DOI:10.1159/000481628)
Free Access
Original Article
574

Clinical Correlates and Prognostic Significance of IL-8, sIL-2R, and Immunoglobulin-Free Light Chain Levels in Patients with Myelofibrosis

Barabanshikova M.V. · Dubina I.A. · Lapin S.V. · Morozova E.V. · Vlasova J.J. · Ivanova M.O. · Moiseev I.S. · Afanasyev B.V.
Oncol Res Treat 2017;40:574-578 (DOI:10.1159/000477253)
579

Magnetic Resonance Features and Characteristic Vascular Pattern of Alveolar Soft-Part Sarcoma

Cui J.-F. · Chen H.-S. · Hao D.-P. · Liu J.-H. · Hou F. · Xu W.-J.
Oncol Res Treat 2017;40:580-585 (DOI:10.1159/000477443)
585

Generation of a Potential Prognostic Matrix for Papillary Thyroid Cancer that Assesses Age, Tumor Size, Transforming Growth Factor-β, and BRAFV600E Mutation

Wang P. · Lun Y. · Fu Y. · Wang F. · Zhao S. · Wang Y. · Hou X.
Oncol Res Treat 2017;40:586-592 (DOI:10.1159/000477909)
592

Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma

Katono K. · Sato Y. · Kobayashi M. · Saito K. · Nagashio R. · Ryuge S. · Igawa S. · Nakashima H. · Shiomi K. · Satoh Y. · Ichinoe M · Murakumo Y. · Saegusa M. · Masuda N.
Oncol Res Treat 2017;40:594-602 (DOI:10.1159/000478100)
601

Increased Percentage of mo-MDSCs in Human Peripheral Blood May Be a Potential Indicator in the Diagnosis of Breast Cancer

Jin G. · Zhang Y. · Chang X. · Zhang Y. · Xu J. · Wei M. · Zeng X.
Oncol Res Treat 2017;40:603-608 (DOI:10.1159/000478933)
607

Specific Characteristics of Patients with Advanced Genitourinary Cancer Receiving Specialized Inpatient Palliative Care

Iversen K. · Oechsle K. · Oing C. · Bokemeyer C. · Seidel C.
Oncol Res Treat 2017;40:609-614 (DOI:10.1159/000478934)
613

The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients

Bila J. · Jelicic J. · Dencic Fekete M. · Trajkovic G. · Sretenovic A. · Perunicic Jovanovic M. · Antic D. · Mihaljevic B.
Oncol Res Treat 2017;40:616-620 (DOI:10.1159/000478935)
Letter to the Editors
618

Immune Thrombocytopenia Induced by Nivolumab in a Metastatic Non-Small Cell Lung Cancer Patient

Karakas Y. · Yuce D. · Kılıckap S.
Oncol Res Treat 2017;40:621-622 (DOI:10.1159/000477968)
Free Access
 
620

Erratum

Oncol Res Treat 2017;40:622 (DOI:10.1159/000481330)
Free Access
621

Society Bulletins

Oncol Res Treat 2017;40:623-627 (DOI:10.1159/000481298)
Free Access
PharmaForum
627

Daten zum Wirkmechanismus liefern Ansatzpunkte für weitere Einsatzmöglichkeiten

Oncol Res Treat 2017;40:629 (DOI:10.1159/000481597)
MyKarger login required
Free Access
628

Erstes Rituximab-Biosimilar ermöglicht sichere und qualitiv hochwertige Behandlung von B-Zell-Lymphomen

Oncol Res Treat 2017;40:630-631 (DOI:10.1159/000481598)
MyKarger login required
Free Access
630

Darzalex®: Neuer Standard in der Zweitlinientherapie

Oncol Res Treat 2017;40:632-633 (DOI:10.1159/000481599)
MyKarger login required
Free Access
 
633

PharmaNews

Oncol Res Treat 2017;40:635 (DOI:10.1159/000481600)
MyKarger login required
Free Access
634

PharmaNews

Oncol Res Treat 2017;40:636 (DOI:10.1159/000481601)
MyKarger login required
Free Access
635

PharmaNews

Oncol Res Treat 2017;40:637 (DOI:10.1159/000481602)
MyKarger login required
Free Access
636

PharmaNews

Oncol Res Treat 2017;40:638-640 (DOI:10.1159/000481749)
MyKarger login required
Free Access
640

Meetings and Conferences

Oncol Res Treat 2017;40:642-644 (DOI:10.1159/000481297)
Free Access
 
I

OnkoImmun 3/17

Oncol Res Treat 2017;40:I-VIII (DOI:10.1159/000481608)
MyKarger login required
Free Access